Articles
Drug Science publish regular articles that analyse developments in drug science and policy to highlight areas of improvement based on evidence
For far too long school students have been denied access to the truth about drugs, which has undermined their trust in health information in general and put them at greater risk of harm. This new initiative sets out to rectify this failure by presenting teaching materials that are evidence-based, balanced and…
- April 22, 2022
Get Project Twenty21 Updates via Email Project Twenty21 April Update This month we're celebrating another fantastic clinic joining us, plus some of the exciting events that we're involved with in the coming weeks - including one organised by a Twenty21 patient. And there's even more in the pipeline - as always, we'll…
- April 15, 2022
Get Project Twenty21 Updates via Email Spring is definitely here - our website has undergone a Spring-clean, we're continuing to see encouraging results from our data analysis and there are lots of events (both virtual and in-person) on the horizon where we'll be spreading the word about medical cannabis. We've got…
- March 18, 2022
The last decade has seen a new focus on psychedelics as powerful medicines for treating severe mental health issues, including the use of psilocybin for conditions such as PTSD and treatment-resistant depression. However, many of these potentially life-saving treatments, including psilocybin, remain difficult to research due to overly strict drug laws.…
- March 7, 2022
By Adam Winstock, Rasmus Munksgaard, Emma Davies, Jason Ferris, Ahnjili ZhuParris, Monica Barratt Full report can be found on The Global Drug Survey website. Background People are not defined by the drugs they use. This report is based on our non-probability data collected from 592,000 people completing our online survey,…
- March 1, 2022
UK Drugs Inquiry: Drug Science Response
In 2019, Drug Science submitted evidence to the Drugs Policy Inquiry by the Health and Social Care Committee. In 2020, we prepared a detailed report in response to the Dame Carol Black Drugs Review. In 2021, we reacted to the government’s 10-year Drug Strategy. Our 2022 response to the UK government’s…